| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1999;34:51-56.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Blood Pressure and the Progression of Carotid Atherosclerosis in Middle-Aged Men
From the Research Institute of Public Health, University of Kuopio, Kuopio, Finland (T.A.L., J.T.S., R.S.), and the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Mich (G.A.K.).
Correspondence to Timo A. Lakka, MD, PhD, Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland. E-mail timo.lakka{at}uku.fi
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—Elevated blood pressure has consistently been associated with increased prevalence of preclinical atherosclerosis and with increased risk of clinical atherosclerotic cardiovascular disease (CVD). However, there is no prospective evidence of the association between blood pressure and the progression of preclinical atherosclerosis. We therefore investigated the relationships of systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure to the 4-year increase in the measures of early carotid atherosclerosis, the mean and maximal common carotid intima-media thickness (IMT), assessed by B-mode ultrasonography, in 1026 men aged 42 to 60 years. Men with the SBP of <120, 120 to 126, 127 to 134, 135 to 143, and >143 mm Hg (fifths) had an increase in the mean IMT of 0.074, 0.090, 0.110, 0.136, and 0.158 mm per 4 years (P<0.001 for difference between groups, P<0.001 for linear trend) and in the maximal IMT of 0.212, 0.221, 0.279, 0.286, and 0.315 mm per 4 years, (P<0.001, P<0.001), respectively, adjusting for other atherosclerotic risk factors, including DBP. Also, pulse pressure, when adjusted for other risk factors including mean arterial pressure, was directly associated with the IMT increase. DBP was not independently related to the IMT increase. This is the first documentation to show that mildly elevated SBP and pulse pressure accelerate the progression of preclinical atherosclerosis. This study provides further evidence for the finding that systolic hypertension is a more important risk factor for atherosclerosis and consequent CVD than diastolic hypertension. Therefore, more attention should be paid to the level of SBP in the evaluation of CVD risk and in the treatment of hypertension.
Key Words: atherosclerosis • ultrasonography • blood
pressure • hypertension, mild • population
studies • pulse pressure
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Basic research has suggested that hypertension plays an important role in the pathogenesis of atherosclerosis.1 2 Indeed, elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP) have consistently been associated with increased risk of atherosclerotic cardiovascular disease (CVD) in prospective population studies.3 4 5 Additional evidence for the role of hypertension as a predictor of CVD derives from randomized trials,6 7 8 9 in which the treatment of elevated blood pressure (BP) with antihypertensive drugs has reduced CVD risk. Even mildly elevated SBP and DBP have been related to increased CVD risk in prospective population studies.3 4 5 Support for this finding comes from randomized trials6 9 that have shown a large cardiovascular benefit from the treatment of uncomplicated mild hypertension.
Decisions about the initiation of antihypertensive medication have usually been based on the level of DBP.3 7 According to some prospective population studies,4 5 however, systolic hypertension may be a more important CVD risk factor than diastolic hypertension. Consistently, elevated SBP but not elevated DBP has been associated with increased prevalence of early atherosclerotic manifestations, including carotid intima-media thickening, in cross-sectional studies.10 11 12 13 Additional evidence for the role of systolic hypertension in CVD derives from a randomized trial, in which the treatment of elevated SBP with antihypertensive drugs slowed the progression of carotid stenosis14 and reduced CVD risk8 in older persons with isolated systolic hypertension. Some studies have also emphasized elevated pulse pressure as a risk factor for atherosclerosis11 12 13 and consequent CVD.15 16
There are no previous reports from prospective population studies of the association between BP and the progression of preclinical atherosclerosis. We therefore investigated the relationships of SBP, DBP, and pulse pressure to the 4-year increase in the measures of early carotid atherosclerosis, the mean and maximal intima-media thickness (IMT) in the common carotid arteries (CCAs), in a population-based sample of middle-aged men from eastern Finland.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Subjects
The subjects were participants in the Kuopio Ischemic Heart Disease Risk Factor Study (KIHD), which is an ongoing population study designed to investigate risk factors for CVD, atherosclerosis, and related outcomes in men from eastern Finland.17 The recruitment of the subjects has been explained in detail previously.17 The KIHD was approved by the Research Ethics Committee of the University of Kuopio, Kuopio, Finland. Each subject gave written informed consent to participate in the study. A total of 1229 men who had undergone ultrasound examination of the carotid arteries at the KIHD baseline between August 1986 and December 1989 were invited to participate in a 4-year follow-up study between March 1991 and December 1993. Of these men, 1038 (88.2%) participated, 107 refused, 52 could not participate because of death, severe illness, or relocation, and 32 could not be contacted. Average time to follow-up was 4.2 years (range 3.8 to 5.2 years). This study is based on data from the 1026 men who had complete information on BP and carotid atherosclerosis. Of these men, 73 had been in the pravastatin treatment group in the Kuopio Atherosclerosis Prevention Study (KAPS) for 3 years.18 We included these men in the present study because the association between BP and atherosclerotic progression remained similar regardless of whether these men were included.
Measurement of BP
BP was measured
with a random-zero mercury sphygmomanometer (Hawksley) between 8:00
and 10:00 AM. The measurement protocol included a supine
rest of 5 minutes, then 3 measurements with subjects in the supine
position, 1 measurement with subjects in the standing position, and 2
measurements with subjects in the seated position at 5-minute
intervals. The mean of all 6 values was used as a measure of BP in the
present study.
Assessment of Carotid
Atherosclerosis
The extent and severity of carotid
atherosclerosis was assessed by high-resolution B-mode ultrasonography
of the right and left CCA of a 1.0- to 1.5-cm section at the distal
end of the CCA proximal to the carotid bulb as explained in detail
previously.19 The mean
and maximal IMT were used as the measures of carotid atherosclerosis
in the present study. The mean IMT was calculated as the mean of
100 IMT estimates from the right and left CCA and was used as an
overall measure of the atherosclerotic process. The maximal IMT was
calculated as the average of the points of maximal thickness from the
right and left CCA and was used as an indicator of the depth of
intima-media protrusion into the lumen in this part of the CCA. The
baseline ultrasonographic findings were classified into 4 categories
according to their severity: (1) no atherosclerotic lesion, (2)
intima-media thickening (a distance of >1.0 mm between the
lumen/intima and the media/adventitia interfaces), (3) a nonstenotic
plaque (a distinct area of mineralization or focal protrusion into the
lumen), and (4) a large, stenotic plaque (obstruction of >20% of
the lumen diameter).19
Assessment of Covariates
The examination
protocol,17 the
assessment of medical history, medications, cigarette smoking, the
dietary intake of iron and vitamin C, alcohol consumption,20 maximal oxygen uptake
(
O2
max),21 body mass
index (BMI), waist-to-hip ratio,22 and hair mercury
content20 have been
described previously. The collection of blood specimens and the
measurement of serum lipids,20 blood glucose, serum
insulin,22 and plasma
fibrinogen20 have been
explained previously.
Statistical Methods
The
baseline associations of BP with covariates were investigated with
univariate regression analysis. The strongest baseline risk factors
for the IMT increase were determined by entering each variable
individually into the multivariate regression model with the technical
covariates (examination years, the zooming depth at baseline for right
and left side, the baseline mean or maximal IMT, sonographer,
follow-up time, and pravastatin treatment in the KAPS). The
heterogeneity of the means of the IMT increase across the fifths of BP
was examined with covariance analysis, and the linear trend was tested
with multivariate regression analysis. All analyses included the
technical covariates. Other covariates were selected based on their
statistical significance (P<0.20) versus all variables
shown in Table 1 and were entered
into the same step-up multivariate regression model. These variables
included age, treatment for dyslipidemia, cigarette smoking, iron and
vitamin C intake, O2
max, hair mercury content, serum HDL cholesterol, and
waist-to-hip ratio. All statistical analyses were conducted with
procedures from SAS, version 6.09, installed on an IBM
RS/6000.
|
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
BP and Other Baseline Characteristics
Baseline characteristics are shown in Table 1. SBP had unadjusted direct associations with BMI, waist-to-hip ratio, fasting serum insulin, serum triglycerides (P<0.001); the baseline mean IMT and type 2 diabetes (P=0.001); age (P=0.005); the baseline maximal IMT (P=0.006); and serum apolipoprotein B (P=0.01). SBP had inverse relationships with
O2 max
(P<0.001) and treatment for dyslipidemia
(P=0.02). DBP had unadjusted direct associations with
BMI, waist-to-hip ratio, fasting serum insulin, serum triglycerides
(P<0.001); and serum apolipoprotein B
(P=0.001). DBP had inverse relationships with iron
intake (P=0.003);
O2 max
(P=0.005); treatment for dyslipidemia
(P=0.02); vitamin C intake and baseline maximal IMT
(P=0.04); and age
(P=0.05).
Strongest Baseline Risk
Factors for 4-Year Increase in the Mean and Maximal IMT
The
strongest baseline risk factors for the IMT increase were high hair
mercury content, elevated pulse pressure, high age, low
O2 max, treatment
for dyslipidemia, elevated SBP, cigarette smoking, increased plasma
fibrinogen, high iron intake, and high waist-to-hip ratio (Table
2).
|
Baseline BP
and 4-Year Increase in the Mean and Maximal IMT
SBP had a
strong, direct, and graded association with the increase in the mean
and maximal IMT when adjusted for other risk factors (Table
3). These relationships were even
stronger after further adjustment for DBP. The difference in the
increase in the mean IMT between the highest and lowest fifth was 57%
adjusted for other risk factors and 114% after additional adjustment
for DBP. The respective differences in the increase in the maximal IMT
were 33% and 49%. DBP had a weak, direct association with the increase
in the maximal IMT when adjusted for other risk factors but not after
further adjustment for SBP (Table 3). DBP was not related to the increase in the
mean IMT. SBP was associated directly with the increase in the mean
and maximal IMT at each level of DBP, whereas DBP had no consistent
relationship with the IMT increase at different levels of SBP
(Figure). Pulse pressure was
directly associated with the increase in the mean and maximal IMT when
adjusted for other risk factors (Table 3). These relationships were slightly weaker
after additional adjustment for mean arterial pressure. The difference
in the increase in the mean IMT between the highest and lowest fifth
was 64% when adjusted for other risk factors and 57% when also
adjusted for mean arterial pressure. The respective differences in
increase in maximal IMT were 30% and 22%.
|
|
Baseline
IMT and the 4-Year Increase in BP
The mean IMT had an
unadjusted direct association with the increase in SBP
(P=0.005) and pulse pressure
(P<0.001). Also, the maximal IMT had an unadjusted direct
relationship with the increase in SBP (P=0.01) and
pulse pressure (P<0.001). These associations disappeared
after further adjustment for age. The IMT was not related to the
change in DBP.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This 4-year follow-up study in middle-aged men provides the first prospective evidence that mildly elevated SBP and pulse pressure accelerate the progression of preclinical atherosclerosis, quantified by the mean and maximal IMT in the CCAs. SBP had a strong, graded, and direct association with the IMT increase regardless of the level of DBP, whereas DBP had no relationship with the IMT increase when controlled for SBP. Intima-media thickening started to accelerate at the SBP of approximately 120 mm Hg and at the pulse pressure of
36 mm
Hg. Interestingly, intima-media thickening was the most rapid in men
with SBP of >140 mm Hg and DBP of <85 mm Hg. Taken together with prospective studies of CVD events,3 4 5 the present study shows that even mildly elevated BP is a risk factor for atherosclerosis and consequent CVD. Similar to the results of cross-sectional studies of early atherosclerotic manifestations10 11 12 13 and prospective studies of CVD events,4 5 15 16 our findings suggest that systolic hypertension is a more important risk factor for atherosclerosis and CVD than diastolic hypertension and that elevated pulse pressure also increases the risk of atherosclerotic CVD. Interestingly, some other studies have suggested that elevated SBP is also a risk factor for early atherosclerosis in populations with a high prevalence of hypertension but a relatively low prevalence of atherosclerosis and hypercholesterolemia, such as in the Japanese.23 Our findings provide one explanation for the effectiveness of antihypertensive medication in reducing CVD risk in persons with uncomplicated mild hypertension6 9 or isolated systolic hypertension.8 They also are in agreement with the reduced treatment goals for hypertension recommended by the Joint National Committee24 and the World Health Organization/International Hypertension Society.25
Previous studies11 12 13 have not been able to draw a conclusion about the time order of the relationship between BP and atherosclerosis due to their cross-sectional study design. In our prospective study, baseline SBP and pulse pressure were directly and independently associated with the IMT increase, which suggests that systolic hypertension and high pulse pressure are true atherosclerotic risk factors. However, baseline IMT was also associated directly with the increase in SBP and pulse pressure. Such a reciprocal relationship indicates a vicious cycle between baseline BP and IMT in the central conduit vessels. In other words, the increase in IMT and artery wall stiffness is associated with elevated SBP and pulse pressure at baseline due to the relative stiffness of the artery wall, and further stiffening would be related to a greater increase in BP. However, this phenomenon appears to occur mainly in older individuals, because the association between baseline IMT and the increase in BP disappeared when data were controlled for age.
In the Systolic Hypertension in the Elderly Program (SHEP),14 the progression of carotid stenosis, quantified by blood flow velocity and extent of plaque, was slower in the diuretic and/or ß-blocker group than in the placebo group, which suggests a causal association between systolic hypertension and atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)26 did not, however, provide evidence for a causal relationship, because the carotid IMT increased less over the first 6 months of the trial in spite of a slightly higher SBP in the isradipine group than in the hydrochlorothiazide group. Ongoing trials27 will provide further information about the effect of lowered BP on intima-media thickening.
Carotid IMT, assessed by ultrasonography, has been regarded as a valid indicator of generalized atherosclerosis, because it has been related to atherosclerotic risk factors, coronary and peripheral atherosclerosis, and the risk of coronary and cerebrovascular events.19 28 29 30 However, it has been criticized as an indicator of atherosclerosis, because the intima cannot be discriminated from the media using ultrasonography. Thus, it is likely that the IMT increase observed in our study is not only due to atherosclerotic intimal thickening but also due to medial hypertrophy caused by the hemodynamic stimulation of a progressive increase in SBP, pulse pressure, or arterial diameter over time.
Hypertension could cause atherosclerosis through a number of plausible mechanisms, which have been reviewed in detail previously.1 2 Briefly, hypertension has been associated with (1) impaired endothelium-dependent arterial relaxation, (2) enhanced monocyte and lymphocyte adherence to the endothelium and migration into the intima, (3) enhanced macrophage accumulation in the intima, (4) stimulated growth factor and cytokine expression, (5) stimulated smooth-muscle cell proliferation, (6) increased plaque cellularity, (7) increased susceptibility to intimal tears due to increased medial collagen synthesis and reduced arterial wall elasticity, (8) increased vascular oxidative stress and oxygen-free radical production by the arterial wall, and (9) increased hypoxia caused by increased diffusion distances due to intimal and medial thickening.
The results of the present study are important from both a clinical and public health viewpoint. This is the first documentation that mildly elevated SBP and pulse pressure accelerate the progression of preclinical atherosclerosis in middle-aged men with increased CVD risk. This study provides further evidence for the finding that systolic hypertension is a more important risk factor for atherosclerosis and consequent CVD than is diastolic hypertension. Therefore, more attention should be paid to the level of SBP in the evaluation of CVD risk and in the treatment of hypertension.
|
Acknowledgments |
|---|
We thank Kimmo Ronkainen for data analyses and Kristiina Nyyssönen and Kari Seppänen for supervising laboratory measurements. The KIHD was supported by grants from the Academy of Finland, the Finnish Ministry of Education and the National Heart, Lung, and Blood Institute of the USA (grant HL-44199). Timo Lakka was supported by a grant from the Yrjö Jahnsson Foundation. Jukka T. Salonen was an Academy Professor of the Academy of Finland.
Received November 24, 1998; first decision December 24, 1998; accepted March 1, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Alexander RW. Theodore Cooper Memorial Lecture: hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension.1995 ;25:155–161.
2.
Chobanian AV, Alexander RW. Exacerbation
of atherosclerosis by hypertension: potential mechanisms and clinical
implications. Arch Intern Med.1996
;156:1952–1956.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Codwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet.1990 ;335:765–774.[Medline] [Order article via Infotrieve]
4.
Stamler J, Stamler R, Neaton JD. Blood
pressure, systolic and diastolic, and cardiovascular
risk. Arch Intern Med.1993
;153:598–615.
5.
Kannel WB. Blood pressure as a
cardiovascular risk factor: prevention and treatment.
JAMA.1996
;275:1571–576.
6.
Hypertension Detection and Follow-up
Program Cooperative Group. Five-year findings of the Hypertension
Detection and Follow-up Program, I: reduction in mortality of persons
with high blood pressure, including mild
hypertension. JAMA.1979
;242:2562–2571.
7. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet.1990 ;335:827–838.[Medline] [Order article via Infotrieve]
8.
SHEP Cooperative Research
Group. Prevention of stroke by antihypertensive drug treatment in
older persons with isolated systolic hypertension: final results of
the Systolic Hypertension in the Elderly Program
(SHEP). JAMA.1991
;265:3255–3264.
9. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J Rahn KH, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet.1998 ;351:1755–1762.[Medline] [Order article via Infotrieve]
10. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonographic study in eastern Finnish men. J Intern Med.1991 ;229:225–231.[Medline] [Order article via Infotrieve]
11.
Psaty BM, Furberg CD, Kuller LH,
Borhani NO, Rautaharju PM, O'Leary DH, Bild DE, Robbins J, Fried
LP, Reid C. Isolated systolic hypertension and subclinical
cardiovascular disease in the elderly: initial findings from the
Cardiovascular Health Study. JAMA.1992
;268:1287–1291.
12.
Bots ML, Hofman A, de Bruyn AM, de Jong
PTVM, Grobbee DE. Isolated systolic hypertension and vessel wall
thickness of the carotid artery: the Rotterdam Elderly
Study. Arterioscler Thromb.1993
;13:64–69.
13.
Arnett DK, Tyroler HA, Burke G,
Hutchinson R, Howard G, Heiss G. Hypertension and subclinical carotid
artery atherosclerosis in blacks and whites: the Atherosclerosis Risk
in Communities Study. Arch Intern Med.1996
;156:1983–1989.
14. Sutton-Tyrrell K, Wolfson SK, Kuller LH. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic blood pressure. Stroke.1994 ;25:44–50.[Abstract]
15.
Madhavan S, Ooi WL, Cohen H, Alderman
MH. Relation of pulse pressure and blood pressure reduction to the
incidence of myocardial
infarction. Hypertension.1994
;23:395–401.
16.
Benetos A, Safar M, Rudnichi A, Smulyan
H, Richard J-L, Ducimetiere P, Guize L. Pulse pressure: a predictor of
long-term cardiovascular mortality in a French male population.
Hypertension.1997
;30:1410–1415.
17. Salonen JT. Is there a continuing need for longitudinal epidemiologic research: the Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res.1988 ;20:46–50.[Medline] [Order article via Infotrieve]
18.
Salonen R, Nyyssönen K, Porkkala
E, Rummukainen J, Belder R, Park JS, Salonen JT. Kuopio
Atherosclerosis Prevention Study (KAPS): a population-based primary
preventive trial of the effect of LDL lowering on atherosclerotic
progression in carotid and femoral arteries.
Circulation.1995
;92:1758–1764.
19. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87 Suppl II:II-56–II-65.
20.
Salonen JT, Seppänen K,
Nyyssönen K, Korpela H, Kauhanen J, Kantola M, Tuomilehto J,
Esterbauer H, Tatzber F, Salonen R. Intake of mercury from fish, lipid
peroxidation and the risk of myocardial infarction and coronary,
cardiovascular and any death in Eastern Finnish men.
Circulation.1995
;91:645–655.
21.
Lakka TA, Venäläinen JM,
Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of
leisure-time physical activity and cardiorespiratory fitness to the
risk of acute myocardial infarction in men. N Engl J
Med.1994
;330:1549–1554.
22. Salonen JT, Lakka TA, Lakka H-M, Valkonen V-P, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes.1998 ;47:270–275.[Abstract]
23.
Mannami T, Konishi M, Baba S, Nishi N,
Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions
detected by high-resolution ultrasonography and its relation to
cardiovascular risk factors in the general population of a Japanese
city: the Suita study. Stroke.1997
;28:518–525.
24.
The Sixth Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure. Arch Intern Med.1997
;157:2413–2446.
25. Zanchetti A. Guidelines for the management of hypertension: the World Health Organization/International Society of Hypertension view: World Health Organization: International Society of Hypertension. J Hypertens Suppl.1995 ;13:119–122.
26.
Borhani NO, Mercuri M, Borhani PA,
Buckalew VM, Canossa-Terris M, Carr AA, Kappagoda T, Rocco MV,
Schnaper HW, Sowers JR, Bond G. Final outcome results of the
Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a
randomized controlled trial. JAMA.1996
;276:785–791.
27. Zanchetti A. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. J Hypertens Suppl.1996;14:S77–S80.
28. Crouse JR, Thompson CJ. An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation. 1993;87(suppl II):II-17–II-33.
29.
Craven TE, Ryu JE, Espeland MA, Kahl
FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR
III. Evaluation of the associations between carotid artery
atherosclerosis and coronary artery stenosis: a case-control
study. Circulation.1990
;82:1230–1242.
30.
Bots ML, Hoes AW, Koudstaal PJ, Hofman
A, Grobbee DE. Common carotid intima-media thickness and the risk of
stroke and myocardial infarction: The Rotterdam
Study. Circulation.1997
;96:1432–1437.
This article has been cited by other articles:
 |
|
 |
|
  M. Puato, P. Palatini, M. Zanardo, F. Dorigatti, C. Tirrito, M. Rattazzi, and P. Pauletto Increase in Carotid Intima-Media Thickness in Grade I Hypertensive Subjects: White-Coat Versus Sustained Hypertension Hypertension, May 1, 2008; 51(5): 1300 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Moriya, M. Oka, K. Maesato, T. Mano, R. Ikee, T. Ohtake, and S. Kobayashi Weekly Averaged Blood Pressure Is More Important than a Single-Point Blood Pressure Measurement in the Risk Stratification of Dialysis Patients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 416 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhu, G. Su, and Q. H. Meng Inhibitory Effects of Micronized Fenofibrate on Carotid Atherosclerosis in Patients with Essential Hypertension Clin. Chem., November 1, 2006; 52(11): 2036 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Tsivgoulis, K Spengos, N Zakopoulos, E Manios, K Xinos, D Vassilopoulos, and K N Vemmos Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1360 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hashimoto, K. Kitagawa, H. Hougaku, H. Etani, and M. Hori Relationship Between C-Reactive Protein and Progression of Early Carotid Atherosclerosis in Hypertensive Subjects Stroke, July 1, 2004; 35(7): 1625 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukai, M. Gagnon, I. Iloputaife, J. W. Hamner, and L. A. Lipsitz Effect of Systolic Blood Pressure and Carotid Stiffness on Baroreflex Gain in Elderly Subjects J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Wagenknecht, D. Zaccaro, M. A. Espeland, A. J. Karter, D. H. O'Leary, and S. M. Haffner Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1035 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Oliviero, G. Scherillo, C. Casaburi, M. di Martino, A. di Gianni, R. Serpico, S. Fazio, and L. Sacca Prospective Evaluation of Hypertensive Patients with Carotid Kinking and Coiling: An Ultrasonographic 7-Year Study Angiology, March 1, 2003; 54(2): 169 - 175. [Abstract] [PDF]
|
|
|
|
|
|
I. M. van der Meer, M. P.M. de Maat, A. E. Hak, A. J. Kiliaan, A. I. del Sol, D. A.M. van der Kuip, R. L.G. Nijhuis, A. Hofman, and J. C.M. Witteman C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study Stroke, December 1, 2002; 33(12): 2750 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Crouse III, R. Tang, M. A. Espeland, J. G. Terry, T. Morgan, and M. Mercuri Associations of Extracranial Carotid Atherosclerosis Progression With Coronary Status and Risk Factors in Patients With and Without Coronary Artery Disease Circulation, October 15, 2002; 106(16): 2061 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Weber Risk factors for subclinical carotid atherosclerosis in healthy men Neurology, August 27, 2002; 59(4): 524 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rafael, Y.-T. Lee, T.-C. Su, J.-S. Jeng, and F.-C. Sung Cerebral Atherosclerosis Causes Neurogenic Hypertension Stroke, May 1, 2002; 33(5): 1180 - 1181. [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Chambless, A. R. Folsom, V. Davis, R. Sharrett, G. Heiss, P. Sorlie, M. Szklo, G. Howard, and G. W. Evans Risk Factors for Progression of Common Carotid Atherosclerosis: The Atherosclerosis Risk in Communities Study, 1987-1998 Am. J. Epidemiol., January 1, 2002; 155(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kurl, J. A. Laukkanen, R. Rauramaa, T. A. Lakka, J. Sivenius, and J. T. Salonen Systolic Blood Pressure Response to Exercise Stress Test and Risk of Stroke Stroke, September 1, 2001; 32(9): 2036 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Simon, J. Gariepy, D. Moyse, and J. Levenson Differential Effects of Nifedipine and Co-Amilozide on the Progression of Early Carotid Wall Changes Circulation, June 19, 2001; 103(24): 2949 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Snapir, P. Heinonen, T.-P. Tuomainen, P. Alhopuro, M. K. Karvonen, T. A. Lakka, K. Nyyssonen, R. Salonen, J. Kauhanen, V.-P. Valkonen, et al. An insertion/deletion polymorphism in the {alpha}2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1516 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sander, C. Kukla, J. Klingelhofer, K. Winbeck, and B. Conrad Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis : A 3-Year Follow-Up Study Circulation, September 26, 2000; 102(13): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. August Hypertension in Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3451 - 3454. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||